BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ning P, Zhong J, Jiang F, Zhang Y, Zhao J, Tian F, Li W. Role of protein S in castration-resistant prostate cancer-like cells. Endocrine-Related Cancer 2016;23:595-607. [DOI: 10.1530/erc-16-0126] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Bennett JL, Jackson BN, Miller RJ, Tsui H, Martin-caraballo M. IL-6 evoked biochemical changes in prostate cancer cells. Cytokine 2023;161:156079. [DOI: 10.1016/j.cyto.2022.156079] [Reference Citation Analysis]
2 Wei M, Wang Y, Liu Y, Li D, He X. AXL, along with PROS1, is overexpressed in papillary thyroid carcinoma and regulates its biological behaviour. World J Surg Oncol 2022;20:334. [PMID: 36203174 DOI: 10.1186/s12957-022-02801-0] [Reference Citation Analysis]
3 Welsh J, Bak MJ, Narvaez CJ. New insights into vitamin K biology with relevance to cancer. Trends Mol Med 2022:S1471-4914(22)00182-4. [PMID: 36028390 DOI: 10.1016/j.molmed.2022.07.002] [Reference Citation Analysis]
4 Jeong SA, Yang C, Song J, Song G, Jeong W, Lim W. Hesperidin Suppresses the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress and Disrupting Ca2+ Homeostasis. Antioxidants 2022;11:1633. [DOI: 10.3390/antiox11091633] [Reference Citation Analysis]
5 Kaler C, Dollar J, Cruz A, Kuznetsoff J, Sanchez M, Decatur C, Licht J, Smalley K, Correa Z, Kurtenbach S, Harbour J. BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas. Cancers 2022;14:3678. [DOI: 10.3390/cancers14153678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Suleiman L, Muataz Y, Négrier C, Boukerche H. Protein S-mediated signal transduction pathway regulates lung cancer cell proliferation, migration and angiogenesis. Hematol Oncol Stem Cell Ther 2021:S1658-3876(21)00111-4. [PMID: 34906536 DOI: 10.1016/j.hemonc.2021.11.002] [Reference Citation Analysis]
7 Wu C, Miao C, Tang Q, Zhou X, Xi P, Chang P, Hua L, Ni H. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression. J Cell Mol Med 2020;24:2098-108. [PMID: 31876385 DOI: 10.1111/jcmm.14050] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
8 Hsu PL, Jou J, Tsai SJ. TYRO3: A potential therapeutic target in cancer. Exp Biol Med (Maywood) 2019;244:83-99. [PMID: 30714403 DOI: 10.1177/1535370219828195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
9 Xu YY, Yu HR, Sun JY, Zhao Z, Li S, Zhang XF, Liao ZX, Cui MK, Li J, Li C, Zhang Q. Upregulation of PITX2 Promotes Letrozole Resistance Via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells. Cancer Res Treat 2019;51:576-92. [PMID: 30025446 DOI: 10.4143/crt.2018.100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
10 Shiota M. Oxidative Stress and Castration-Resistant Prostate Cancer. Hormone Therapy and Castration Resistance of Prostate Cancer 2018. [DOI: 10.1007/978-981-10-7013-6_21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Yu T, Yu HR, Sun JY, Zhao Z, Li S, Zhang XF, Liao ZX, Cui MK, Li J, Li C, Zhang Q. miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancer. Oncotarget 2017;8:107134-48. [PMID: 29291017 DOI: 10.18632/oncotarget.22359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
12 Cackowski FC, Eber MR, Rhee J, Decker AM, Yumoto K, Berry JE, Lee E, Shiozawa Y, Jung Y, Aguirre-Ghiso JA, Taichman RS. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy. J Cell Biochem 2017;118:891-902. [PMID: 27753136 DOI: 10.1002/jcb.25768] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 8.3] [Reference Citation Analysis]